Ramsay Sante : quarterly accounts at the end of September 2021
11 November 2021 - 3:35AM
Ramsay Sante : quarterly accounts at the end of September 2021
PRESS
RELEASEParis, 10 November 2021
A continued positive
development in the Nordics but a
more complicated than expected recovery in
business in France due to a
fourth wave of Covid, and staff challenges
- Unaudited
turnover for the three months period ending 30 September 2021
amounted to €936.4m up 2% on a reported basis;
- Unaudited EBITDA
for the three months period ending 30 September 2021 amounted to
€135.1m down -18% on a reported basis;
- Unaudited
current operating profit for the three months period ending 30
September 2021 amounted to €43.5m down -39% on a reported
basis;
- Historically
performance in Q1 is lower than Q2 following the summer period in
Q1 – last year this was the opposite due to the catch-up of volumes
post the first COVID lockdown in France and then Q2 last year was
heavily impacted by the second COVID wave;
- Total sales
growth considering the divestment of the German business in 2020
and changes in exchange rates was approximately 5% in the period
thus continuing the positive trend. The growth was realized despite
the period being impacted by lower patient volumes in France
following the fourth COVID wave whilst the prior year period being
positively impacted by a significant catch-up of volumes post the
lockdown after the first COVID wave. The sales growth includes
compensation for the increase in salaries related to “Ségur” for
the MSO area in France;
- The French
Government has extended the revenue guarantee decree to also being
effective 1 July 2021 to 31 December 2021. The amount of government
subsidies is approximately the same this quarter as last year for
the same period;
- Following the
COVID periods combined with the mandatory vaccination for all staff
in hospitals in France from mid-September has created a shortage of
nurses impacting the speed of ramping-up production post COVID.
Management has full focus on retaining and recruiting nursing staff
to meet the solid underlying volume demand;
- Activity levels
in the Nordics have been solid and driven by specialist care
patients post COVID in both Sweden and Denmark, COVID testing and
vaccination activities;
- The business
remains focused on capturing its share of the strong demand for
healthcare services post the restrictions related to COVID
lockdowns in the last twelve months;
- The Group
continues to deploy its 2025 strategic plan meaning strengthening
the core business and growing through both green- and brownfields
as well as through potential bolt-on acquisitions. Since the
beginning of the current financial year Ramsay Santé has acquired
an ophthalmology clinic in Sweden, signing a transaction to enter
the public primary care market in Denmark and IVF market in
Norway;
- Ramsay Health
Care ltd is publishing in parallel a trading update at the end of
September 2021 which includes some of the information contained in
this announcement.
Pascal Roché, Chief Executive Officer of
Ramsay Santé, says:
« Unlike the first quarter of 2021
(July-September), this quarter was marked, particularly for France,
by a fourth wave of Covid that affected certain regions. Ramsay
Santé continued to manage many Covid patients, while ensuring the
resumption of normal activity, penalized for France by difficulties
in recruiting medical and paramedical staff. On the other hand,
activity was very strong in all the Nordic countries. »
The Board of Directors approved the unaudited first quarter FY22
trading update at its meeting held on 10 November 2021.
About Ramsay
Santé
After the acquisition of Capio AB Group in 2018,
Ramsay Santé has become the leader of the private hospitalization
and primary care in Europe with 36 000 employees and
8 600 practitioners serving 9 million patients in our 350
facilities in five countries: France, Sweden, Norway, Denmark and
Italy.
Ramsay Santé offers almost all medical and
surgical specialties in three business areas: general hospitals
(medicine – surgery – obstetric), follow-up care and rehabilitation
clinics, mental health. In all its territories, the group
contributes to missions of public service and to the territorial
sanitary disposal, as for example in Sweden with more than 100
proximity care units.
The quality and security of care is the group’s
priority. As such our group is today a reference in terms of modern
medicine, especially in outpatient care and enhanced recovery.
Every year, the group invests more than €200
million in innovation whether it is in new surgical or imaging
technologies, in building or modernizing its facilities… The group
also innovates in its organization and digitalization in order to
deliver care in a more efficient way to the benefit of the
patient.
Instagram: https://www.instagram.com/ramsaysanteTwitter:
https://twitter.com/RamsaySanteLinkedIn:
https://www.linkedin.com/company/ramsaysanteYouTube:
https://www.youtube.com/c/RamsaySante
ISIN code and Euronext Paris:
FR0000044471Website:
www.ramsaygds.fr
Investor
Relations/Analysts Press
RelationsMarcus
Nord Brigitte
CachonTél. +46 733 97 72
57 Tél. +33 6 12 29
56 52
Marcus.Nord@capio.com b.cachon@ramsaygds.fr
- Ramsay Santé - quarterly accounts at the end of September
2021
Ramsay Generale De Sante (LSE:0OD6)
Historical Stock Chart
From Apr 2024 to May 2024
Ramsay Generale De Sante (LSE:0OD6)
Historical Stock Chart
From May 2023 to May 2024